SIGA

SIGA Technologies Inc. (SIGA) | Rumor.io

SIGA Technologies

SIGA

Attention (50-day avg)0%

Attention rank (50-day avg)#4,205

Bullish sentiment (50-day avg)100%

Price to earnings ratio11.3

Market capitalization248.6M

Earnings per share-0.04

Dividend yield (TTM)68.9%

Revenue (annual)94.6M

Net income (annual)23.3M

Social

What share of all stock conversation is about SIGA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% -0.06

May 20

SIGA Technologies, Inc. ($SIGA) has a product that is FDA-approved for smallpox antiviral treatment without a black-box mortality warning.
The company has $146M in cash, zero debt, and 49 employees, with its stock near its floor.
The government's commitment to SIGA's product makes it unlikely to walk away, despite Wall Street's lack of interest.

Generated by AI

Sentiment

Of the messages about SIGA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	90.63% +4.14
Bearish	—	—	0% 0	9.38% -4.14

Bullish· Aug 23

SIGA Technologies, Inc. is expected to receive a BARDA contract, which could be a significant catalyst for the stock price.
The company has a strong position, with many shareholders accumulating shares over the past two years and holding significant cards, including BARDA contact, STOMP trail, international orders, and renewed conclusions from the PALM trail.
SIGA's volume has picked up, and the stock is due for a significant move, potentially reaching $20 next week, with many investors expecting a buying frenzy during the last hour of trading.

Bearish· Aug 22

The author believes $SIGA is a "big short trap" and may be due for a price correction.
The stock's performance is being negatively impacted by the success of other MPox-related stocks, leading to a lack of enthusiasm among investors.
The author is concerned about the company's potential for dilution and believes that the stock may be being manipulated by shorts.

Generated by AI

Topics

Of the messages about SIGA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	59.15%
Technical Analysis	—	—	0%	7.75%
Analysts	—	—	0%	0%
Controversies	—	—	0%	4.23%
Earnings	—	—	0%	21.83%
Macro	—	—	0%	7.04%

Earnings· Aug 4

SIGA Technologies reported quarterly earnings of $0.03 per share, a 93% increase over the same period last year, with sales of $16.70 million.
The company expects to deliver $26 million of the $60 million order in the third quarter, indicating a significant revenue increase.
SIGA's balance sheet shows almost no debt and cash on hand increased to $114.5 million at quarter end, indicating a strong financial position.

Announcements· Nov 25

SIGA Technologies is a commercial-stage pharmaceutical company focused on the health security market.
The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus.
SIGA Technologies is a potential hidden gem in the market.

Controversies· Aug 5

The company's monkeypox treatment, Tpoxx, is being used in various settings, including a daycare center in Rantoul where 80 children have been infected.
The FDA is being criticized for not providing enough information on the effectiveness of the Tpoxx vaccine.
The number of monkeypox cases is increasing, with reports of cases in daycares, jails, and other locations, prompting calls to "Protect our Children" and suggesting that the situation may be severe.

Macro· May 12

The post mentions ITSA4, which is likely a ticker for SIGA, but the text does not provide any information about the company or its performance.
There is no mention of SIGA Technologies, Inc. in the provided messages, indicating that the focus is not on the company.
The post does not provide any market-relevant information about SIGA, and the mention of the ticker is likely a mistake or an unrelated reference.

Technical Analysis· Aug 16

SIGA Technologies has formed a potential cup and handle pattern on its weekly chart, with a buy signal expected around $10.80.
The stock has formed a bullish pennant and a bull flag, indicating potential strength and a possible breakout above $11.09.
SIGA has reached major resistance at this level, and a breakout could lead to a significant gap up to $20.

Generated by AI

Community

Of the messages about SIGA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	33.33%	47.81%
Newcomers	0%	0%	66.67%	52.19%

Regulars· Mar 13

SIGA Technologies Inc. reported a significant increase in operating income, up 101% from the same quarter last year, to $91 million.
The company's revenue for Q4 2023 reached $116.5 million, a substantial increase from $11.4 million in Q4 2022.
SIGA's Q4 2023 financial results show a robust growth in revenue and operating income, with the stock price moving up significantly, closing up 21.24% and reaching a 21.15% increase in another session.

Newcomers· Aug 23

New investors are closely watching the stock for a potential rebound, citing a decline in options volume as a potential buying opportunity.
The recent increase in mpox cases is being closely monitored, with some investors speculating that this could lead to an increase in demand for SIGA Technologies' products.
The company's options volume has decreased, with a significant drop in call options, leading some investors to wonder if this is a sign of a potential bear market.

Generated by AI

On August 6, SIGA Technologies (NASDAQ:SIGA) reported financial results for the three and six months ended June 30, and the numbers tell two very different stories depending on which quarter you compare them to. Revenue and profit both cratered from a year ago, yet the company still turned a profit, paid out a special dividend, […]

24d agoYahoo Finance

SIGA Technologies: A Risk Analysis

29d agoSeeking Alpha

SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update

On Track to Deliver $13 Million of Oral TPOXX to an International Customer in Second QuarterExpect to Deliver $26 Million of IV TPOXX to the U.S....

1mo agoBarchart.com

SIGA (SIGA) Q2 2026 Earnings Call Transcript

Detailed price information for Siga Technologies Inc (SIGA-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

SIGA Technologies, Inc. Q2 2026 Earnings Call Summary

Moby summary of SIGA Technologies, Inc.'s Q2 2026 earnings call

1mo agoYahoo Finance

Siga Technologies Q2 Earnings Call Highlights

Siga Technologies (NASDAQ:SIGA) reported second-quarter product-related revenue of $38 million, driven primarily by deliveries of intravenous TPOXX to the U.S. Strategic National Stockpile and oral TPOXX sales to international customers. The company said the quarter reflected the variable timing of

1mo agoYahoo Finance

Also Discussed

Investors talking about SIGA also mention

#	Name	Attention
1	GeoVax Labs, Inc.GOVX	0%+0
2	CMRX - Chimerix, Inc.	——
3	Emergent BioSolutions Inc.EBS	0%new
4	Comera Life Sciences Holdings Inc.CMRA	0%0
5	Magic Empire Global Ltd Class A Ordinary SharesMEGL	0%0
6	Intelligent Living Application Group Inc.ILAG	0%new
7	Aethlon Medical, Inc.AEMD	0%new
8	United Maritime CorporationUSEA	0%0
9	Pliant Therapeutics Inc.PLRX	0%0
10	Veru Inc.VERU	0%0

SIGA Technologies Inc.

Healthcare
Drug Manufacturers - Specialty & Generic

SIGA Technologies Inc. is a commercial-stage pharmaceutical company focused on health security and infectious disease countermeasures. SIGA Technologies Inc. develops and commercializes antiviral medicines designed to address serious threats from orthopoxviruses and other emerging infectious diseases. Its lead product, TPOXX, is an oral antiviral treatment for smallpox, and the company also supplies an intravenous formulation for government use in public health preparedness settings. SIGA Technologies Inc. serves government customers and international markets through direct sales and distribution channels, making it a specialized participant in the biodefense and medical countermeasures segment of the pharmaceutical industry. Based in New York, SIGA Technologies Inc. concentrates on products that support outbreak response, national stockpiling, and treatment access for high-consequence viral diseases.

Website

Location

31 East 62nd Street

New York, NY, 10065

United States

Social

What share of all stock conversation is about SIGA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% -0.06

May 20

SIGA Technologies, Inc. ($SIGA) has a product that is FDA-approved for smallpox antiviral treatment without a black-box mortality warning.
The company has $146M in cash, zero debt, and 49 employees, with its stock near its floor.
The government's commitment to SIGA's product makes it unlikely to walk away, despite Wall Street's lack of interest.

Generated by AI

Sentiment

Of the messages about SIGA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	90.63% +4.14
Bearish	—	—	0% 0	9.38% -4.14

Bullish· Aug 23

SIGA Technologies, Inc. is expected to receive a BARDA contract, which could be a significant catalyst for the stock price.
The company has a strong position, with many shareholders accumulating shares over the past two years and holding significant cards, including BARDA contact, STOMP trail, international orders, and renewed conclusions from the PALM trail.
SIGA's volume has picked up, and the stock is due for a significant move, potentially reaching $20 next week, with many investors expecting a buying frenzy during the last hour of trading.

Bearish· Aug 22

The author believes $SIGA is a "big short trap" and may be due for a price correction.
The stock's performance is being negatively impacted by the success of other MPox-related stocks, leading to a lack of enthusiasm among investors.
The author is concerned about the company's potential for dilution and believes that the stock may be being manipulated by shorts.

Generated by AI

Topics

Of the messages about SIGA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	59.15%
Technical Analysis	—	—	0%	7.75%
Analysts	—	—	0%	0%
Controversies	—	—	0%	4.23%
Earnings	—	—	0%	21.83%
Macro	—	—	0%	7.04%

Earnings· Aug 4

SIGA Technologies reported quarterly earnings of $0.03 per share, a 93% increase over the same period last year, with sales of $16.70 million.
The company expects to deliver $26 million of the $60 million order in the third quarter, indicating a significant revenue increase.
SIGA's balance sheet shows almost no debt and cash on hand increased to $114.5 million at quarter end, indicating a strong financial position.

Announcements· Nov 25

SIGA Technologies is a commercial-stage pharmaceutical company focused on the health security market.
The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus.
SIGA Technologies is a potential hidden gem in the market.

Controversies· Aug 5

The company's monkeypox treatment, Tpoxx, is being used in various settings, including a daycare center in Rantoul where 80 children have been infected.
The FDA is being criticized for not providing enough information on the effectiveness of the Tpoxx vaccine.
The number of monkeypox cases is increasing, with reports of cases in daycares, jails, and other locations, prompting calls to "Protect our Children" and suggesting that the situation may be severe.

Macro· May 12

The post mentions ITSA4, which is likely a ticker for SIGA, but the text does not provide any information about the company or its performance.
There is no mention of SIGA Technologies, Inc. in the provided messages, indicating that the focus is not on the company.
The post does not provide any market-relevant information about SIGA, and the mention of the ticker is likely a mistake or an unrelated reference.

Technical Analysis· Aug 16

SIGA Technologies has formed a potential cup and handle pattern on its weekly chart, with a buy signal expected around $10.80.
The stock has formed a bullish pennant and a bull flag, indicating potential strength and a possible breakout above $11.09.
SIGA has reached major resistance at this level, and a breakout could lead to a significant gap up to $20.

Generated by AI

Community

Of the messages about SIGA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	33.33%	47.81%
Newcomers	0%	0%	66.67%	52.19%

Regulars· Mar 13

SIGA Technologies Inc. reported a significant increase in operating income, up 101% from the same quarter last year, to $91 million.
The company's revenue for Q4 2023 reached $116.5 million, a substantial increase from $11.4 million in Q4 2022.
SIGA's Q4 2023 financial results show a robust growth in revenue and operating income, with the stock price moving up significantly, closing up 21.24% and reaching a 21.15% increase in another session.

Newcomers· Aug 23

New investors are closely watching the stock for a potential rebound, citing a decline in options volume as a potential buying opportunity.
The recent increase in mpox cases is being closely monitored, with some investors speculating that this could lead to an increase in demand for SIGA Technologies' products.
The company's options volume has decreased, with a significant drop in call options, leading some investors to wonder if this is a sign of a potential bear market.

Generated by AI

SIGA Technologies

Social

May 20

Bullish· Aug 23

Bearish· Aug 22

Earnings· Aug 4

Announcements· Nov 25

Controversies· Aug 5

Macro· May 12

Technical Analysis· Aug 16

Regulars· Mar 13

Newcomers· Aug 23

SIGA Tech (SIGA): Profits Drop 65%, But Cash and Special Payouts Remain

SIGA Technologies: A Risk Analysis

SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update

SIGA (SIGA) Q2 2026 Earnings Call Transcript

SIGA Technologies, Inc. Q2 2026 Earnings Call Summary

Siga Technologies Q2 Earnings Call Highlights

Also Discussed

SIGA Technologies Inc.

Company Information

Location

SIGA Tech (SIGA): Profits Drop 65%, But Cash and Special Payouts Remain

SIGA Technologies: A Risk Analysis

SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update

SIGA (SIGA) Q2 2026 Earnings Call Transcript

SIGA Technologies, Inc. Q2 2026 Earnings Call Summary

Siga Technologies Q2 Earnings Call Highlights

Also Discussed

Social

May 20

Bullish· Aug 23

Bearish· Aug 22

Earnings· Aug 4

Announcements· Nov 25

Controversies· Aug 5

Macro· May 12

Technical Analysis· Aug 16

Regulars· Mar 13

Newcomers· Aug 23